Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Dec;26(1):1073274819846590.
doi: 10.1177/1073274819846590.

In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer

Affiliations

In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer

Jie Ni et al. Cancer Control. 2019 Jan-Dec.

Abstract

Prostate cancer (CaP) is the most commonly diagnosed cancer in males in western countries. Orthotopic implantation is considered as an ideal xenograft model for CaP study, and noninvasive measurement of tumor volume changes is important for monitoring responses to anticancer therapies. In this study, the T2-weighted fast spin echo sequence magnetic resonance imaging (MRI) was performed on a CaP orthotopic non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mouse model weekly for 6 weeks post PC-3 CaP cell inoculation, and the fat signal was suppressed using a chemical shift-selective pulse. Subsequently, the MRI data were imported into the image processing software Avizo Standard and stacked into three-dimensional (3D) volumes. Our results demonstrate that MRI, combined with 3D reconstruction, is a feasible and sensitive method to assess tumor growth in a PC-3 orthotopic CaP mouse model and this established monitoring approach is promising for longitudinal observation of CaP xenograft development after anticancer therapy in vivo. Further investigation is needed to validate this protocol in a larger cohort of mice to generate enough statistical power.

Keywords: animal model; magnetic resonance imaging; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Representative MRI images of longitudinal tumor growth in the orthotopic mouse model. A-F, Images were acquired at 1,2,3,4,5, and 6 week(s) post CaP cell inoculation, respectively. A-D were acquired from mouse 1, and E, F were acquired from mouse 2. Prostate cancer (CaP) tumorigenesis as early as 1 week after cell inoculation could be detected, and CaP tumor is clearly delineated from surrounding anatomies. Blue line delineates the prostate gland; Yellow arrow indicates prostate tumor boundaries; red star indicates the urinary bladder. CaP, prostate cancer; MRI, magnetic resonance imaging.
Figure 2.
Figure 2.
Representative 3D reconstructed MRI images of longitudinal tumor growth in the orthotopic mouse model. A-F, Using Avizo Standard software, MRI scan slices acquired from the same mouse were reconstructed into 3D (outlined by blue surface) at 6 different time points, respectively. 3D, three-dimensional; MRI, magnetic resonance imaging.
Figure 3.
Figure 3.
Exponential growth curves for longitudinal 3D volumetric measurements, correlation and agreement of 3D MRI with gross pathology measurements. A, Three-dimensional MRI prostate tumor volumes from the 3 mice were plotted against time, with fitted exponential growth curves, r 2 = 0.968, 0.966, and 0.967, respectively. B, Correlation of 3 paired tumor volumes measured by 3D MRI and gross pathology was demonstrated by linear regression. Pearson r = 0.92, P = .24. C, Good agreement between 3D MRI and gross pathology measurements were plotted and analyzed using Bland-Altman analysis. 3D, three-dimensional; MRI, magnetic resonance imaging; SD, standard deviation.

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. - PubMed
    1. Radiloff DR, Rinella ES, Threadgill DW. Modeling cancer patient populations in mice: complex genetic and environmental factors. Drug Discov Today Dis Models. 2008;4(2):83–88. - PMC - PubMed
    1. Li P, You S, Nguyen C, et al. Genes involved in prostate cancer progression determine MRI visibility. Theranostics. 2018;8(7):1752–1765. - PMC - PubMed
    1. Ravoori M, Duggal J, Gagea M, et al. Visualizing the prostate gland by MR imaging in young and old mice. PLoS One. 2013;8(3):e55746. - PMC - PubMed
    1. Mallett CL, Lim H, Thind K, et al. Longitudinal anatomical and metabolic MRI characterization of orthotopic xenograft prostate tumors in nude mice. J Magn Reson Imaging. 2014;40(4):848–856. - PubMed